Trastuzumab Biosimilar Receives CHMP Recommendation for HER2+ Breast and Gastric Cancer
“Biosimilars have enormous potential to improve cancer care by substantially increasing access to these critical medicines.” The phase 3, …
“Biosimilars have enormous potential to improve cancer care by substantially increasing access to these critical medicines.” The phase 3, …
